Abstract. The annual incidence of leptospirosis in Barbados is approximately 13 severe cases/100,000. The peak incidence occurs in October to December of each year, coinciding with the months of heaviest rainfall. During the second half of 1995, an epidemic of dengue type 1 infection produced almost 1,000 laboratory-confirmed cases. During the same period, leptospirosis mortality was twice the average, suggesting that some cases of leptospirosis were being misdiagnosed and treated inappropriately. Sera from patients investigated for dengue or leptospirosis were analyzed retrospectively to determine the extent of misdiagnosis. During 1995 and 1996, 31 of 139 and 29 of 93 patients, respectively, were confirmed as having leptospirosis. Sera from the remaining leptospirosis-negative patients were tested for IgM antibodies to dengue virus. During 1995 and 1996, 48 of 108 patients and 21 of 64 patients, respectively, were found to have dengue. In 1997, sera from all patients investigated for leptospirosis were also tested prospectively for IgM antibodies to dengue: 38 of 92 leptospirosis-negative patients (41%) were dengue IgM-positive, while 2 of 25 leptospirosis cases also had serologic evidence suggesting acute dengue infection. A second large outbreak of dengue caused by serotype 2 occurred in 1997. During the 1995 and 1997 dengue epidemics in Barbados, dengue cases outnumbered leptospirosis cases investigated in the leptospirosis diagnostic protocol. During 1997, patients investigated but negative for dengue were also tested for anti-leptospiral IgM: 7.3% (19 of 262) were IgMpositive. Substantial misdiagnosis of both dengue and leptospirosis can occur and greater public awareness and clinical suspicion of the similar presentations of these two diseases are necessary.
Dengue fever is included within the group of emerging or re-emerging infectious diseases of public health significance. 1 Outbreaks of dengue have occurred with increasing frequency in Barbados during the past 10 years ( Table 1) . The increasing incidence of dengue in the Caribbean is a cause for concern because epidemics of dengue hemorrhagic fever (DHF) become more likely when multiple serotypes circulate concurrently. 2 A Leptospira Laboratory was established in Barbados in 1979. 3 During the past 20 years, a protocol has evolved for the diagnosis and management of severe leptospirosis cases admitted to the Queen Elizabeth Hospital, the only acute care hospital in Barbados. During this time, the mortality rate has decreased from 15.3% to 9.7% due to both greater clinical expertise and a higher index of suspicion. 4 During the second half of 1995, there was a large increase in admissions to the diagnostic protocol (106 patients compared with a mean of 42 patients in the same period during the preceding 3 years). In addition, during 1995 there were 33 cases of leptospirosis and 7 deaths (mortality rate ϭ 21.2%). In 1995, there was a large epidemic of dengue in Barbados (Table 1) . We formed the hypothesis that the increase in protocol admissions was due to the dengue epidemic and that many dengue cases were undiagnosed, while the increase in leptospirosis mortality was the result of late diagnosis due to diagnostic confusion and/or late presentation of patients who thought they had dengue but in fact had contracted leptospirosis.
PATIENTS AND METHODS

Patients and samples.
Patients who were entered into a diagnostic protocol for leptospirosis 4 at the Queen Elizabeth Hospital in Bridgetown, were entered into this study if their first blood sample was taken in either 1995 or 1996. These samples were studied retrospectively and personal identifiers were not used. The study protocol was approved by the Medical Research and Advisory Committee of the Ministry of Health and the Environment of Barbados. During 1997, all patients who were investigated for leptospirosis were also tested prospectively for IgM antibodies to dengue. In addition, patients suspected of dengue infection, but who were seronegative, were also tested retrospectively for leptospiral IgM antibodies.
Laboratory methods. Diagnostic tests for leptospirosis were used as described previously. 5 Patients enrolled in the leptospirosis diagnostic protocol were investigated by culture of blood and urine in Ellinghausen-McCullough-Johnson-Harris medium (Difco, Detroit, MI) and by serology using the microscopic agglutination test (MAT) and an IgM ELISA. A diagnosis of leptospirosis was confirmed by isolation of leptospires, a 4-fold increase in titer between 2 serum samples tested by the same method, an initial titer Ն800 in the MAT, or an IgM titer Ն160 in the ELISA. 5 Patients who had negative serology for dengue were tested only with the leptospiral IgM ELISA. 6 Dengue IgM antibodies were detected by a monoclonal antibody capture (MAC) ELISA method, using kits supplied by MRL Diagnostics (Cypress, CA). 7 Before use, this assay was validated using a panel of coded sera supplied by a Pan American Health Organization reference laboratory. Dengue IgG antibodies were also detected by ELISA (MRL). 7 
RESULTS
In 1995, a diagnosis of leptospirosis was confirmed in 31 (22%) of 139 patients. Thus, 108 of the patients investigated did not have leptospirosis. Of these patients, 48 (44%) of 108 were shown to have dengue IgM antibodies ( Table 2) . During 1996, 29 (31%) of 93 patients investigated were found to have leptospirosis. Of the remaining 64 patients, 21 (33%) were dengue IgM-positive (Table 2) . Throughout 1997, there were 116 admissions to the diagnostic protocol, of which 25 (22%) were laboratory-confirmed cases of leptospirosis (Table 3 ). An additional 8 of 25 patients with proven leptospirosis also had evidence of previous infection with dengue, indicated by the presence of IgG antibodies. Three patients had evidence of secondary dengue infection or primary dengue in the recent past, with both IgM and IgG antibodies. Two patients also had ELISA results positive for IgM antibodies, but negative for IgG, suggesting primary dengue. One of these patients also had a positive culture for Leptospira kirschneri serovar bim. Of the 91 patients without leptospirosis, 38 (42%) were dengue IgM-positive.
The peak incidence of both leptospirosis and dengue occurs during the rainy season (September to November) (Table 2). However, as we have shown (Tables 2 and 3) , sporadic cases of dengue occur throughout the rainy season. Even in a year without a recognized dengue outbreak, such as in 1996, cases of dengue were detected throughout the rainy season. However, in 1996, unlike the preceding epidemic year, cases of leptospirosis exceeded dengue cases. In all 3 years of this study, cases of dengue were detected throughout the year, indicating continued transmission of the virus.
Leptospiral IgM was detected in 19 (7.3%) of 262 patients who were seronegative when tested for dengue IgM antibodies in 1997. The majority (18 of 19, 95%) of these patients were not hospitalized, confirming that leptospirosis is a common cause of acute febrile illness in the community during the rainy season. 8 Similar findings have been reported recently in other tropical populations. 9 
DISCUSSION
The increasing frequency of dengue outbreaks and the concurrent circulation in the Caribbean region of serotypes 1, 2, and 4 places the Caribbean populations at risk of DHF and dengue shock syndrome (DSS). Dengue hemorrhagic fever was recorded for the first time in Trinidad in 1992-1993, 10 while in 1995, Jamaica recorded 108 cases of DHF and 3 cases of DSS, with a total of 4 deaths. 11 Large outbreaks of dengue occurred in Barbados in 1995 and 1997, and dengue cases detected in the hospital-based diagnostic protocol outnumbered leptospirosis cases. These outbreaks were associated predominantly with circulation of serotype 1 (1995) and serotype 2 (1997), placing the population at high risk of DHF. 12, 13 Dengue hemorrhagic fever was first detected in Barbados in 1995 and five fatalities due to DHF occurred in 1997.
The differential diagnosis of leptospirosis includes dengue, malaria, typhoid fever, viral hepatitis, and human immunodeficiency virus seroconversion. 14 In Barbados, only occasional imported cases of malaria occur, and typhoid fever is a relatively rare infection. Acute hepatitis B infection also occurs in low numbers. However, differentiation on clinical grounds between dengue and leptospirosis may be impossible during the early stages of the illness. In our population, the characteristic rash of dengue may be the only distinguishing feature. Dual infections also occur: we found 2 (8%) of 25 patients with confirmed leptospirosis to have serologic evidence consistent with acute primary dengue infection. We were unable to confirm the presence of dengue viremia in these patients by culture or RNA amplification, and this is the subject of a future study.
Laboratory investigations are therefore mandatory. However, unless there is a high index of clinical suspicion dengue may not be suspected in non-epidemic periods; it is important therefore to establish a sentinel system to detect dengue transmission before an outbreak becomes established. We recognize the limitations of our approach, but patients who are sick enough to warrant hospital admission and investigation for leptospirosis represent one potential sentinel population. 12 Indeed, the first cases of dengue detected in 1997 occurred in such patients; these cases preceded the development of the outbreak by several weeks. Conversely, during a dengue epidemic, the diagnosis of leptospirosis should not be forgotten.
During a dengue epidemic, when public health information is widely broadcast, patients will usually associate a febrile illness with aches and pains with dengue. It is important to educate both patients and physicians that leptospirosis occurs in the same setting, and patients should be carefully assessed and monitored. It is our belief that the late presentation of several patients in the dengue epidemic year of 1995 resulted in the unusually high mortality rate for leptospirosis. Most of these patients were first thought to have dengue.
